Livforsakringsbolaget Skandia, Omsesidigt
Position in CORT — Corcept Therapeutics Inc
CIK 1547926
Stockholm, V7
Position in CORT
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$9,990,989
+$5,359,169 QoQ
Shares Held
114,905
0.0% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#64
of 423 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Livforsakringsbolaget Skandia, Omsesidigt holds $40,172,931 across 9 Biotechnology names. CORT ranks #2 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
293,703 | $15,980,379 | |
| 2 | CORT |
Corcept Therapeutics Inc
This page
|
114,905 | $9,990,989 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
124,100 | $9,713,307 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,780 | $2,871,099 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
772 | $481,372 | |
| 6 | INSM |
INSMED Inc
|
4,412 | $470,407 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,000 | $301,030 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1,000 | $187,280 |
All Filings in CORT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,990,989 | 114,905 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $4,631,820 | 114,905 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,319,680 | 181,600 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,283,116 | 75,600 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $8,305,797 | 113,158 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $228,440 | 2,000 | Shares | Sole | 2025-04-15 | |
| No filing history on record for this holder in this stock. | ||||||